Two BRM Promoter Polymorphisms Predict Poor Survival in Patients with Hepatocellular Carcinoma

CONCLUSION: Two BRM promoter polymorphisms were strongly associated with HCC prognosis but were not associated with increased HCC susceptibility. The association was strongest in double homozygotes for the allele variants. This article is protected by copyright. All rights reserved

Source: Molecular Carcinogenesis - September 11, 2017 Category: Molecular Biology Authors: Ivan Pasic, Kit Man Wong, Jonghun John Lee, Osvaldo Espin ‐Garcia, Yonathan Brhane, Dangxiao Cheng, Zhuo Chen, Devalben Patel, Catherine Brown, Roxana Bucur, David Reisman, Jennifer J Knox, Wei Xu, Rayjean J Hung, Geoffrey Guo, Sean P Cleary Tags: RESEARCH ARTICLE Source Type: research